AllCaps reconciles WAC, contract, and 340B pricing, chargebacks, rebates, and prompt-pay discounts against actual pharmacy purchase files.
Green means the NDC, eligibility basis, chargeback, and rebate all reconcile.
Pharma purchasing leakage often hides in the difference between the price that should have applied and the price the wholesaler or manufacturer settled.
Check contract, WAC, and 340B price basis at the NDC level.
Tie eligible usage and purchasing records to chargeback and rebate outcomes.
Quantify missed discounts and credits without rebuilding every invoice manually.
A single drug can move across WAC, contract, and 340B economics depending on eligibility and purchasing path.
AllCaps checks the NDC, account, eligibility flag, expected price, chargeback, and rebate in one continuous calculation.
Chargeback leakage is often a three-party mismatch between provider, wholesaler, and manufacturer records.
The exception ties the purchasing record to the contract price and the chargeback credit that should have followed.
Covered outpatient drugs purchased through a registered eligible account shall be invoiced at the applicable 340B price when eligibility criteria are met and reconciled through the wholesaler chargeback process.
The roll-up shows where drug spend is clean, where eligibility needs review, and where recovery should be pursued.
That gives pharmacy and finance the same evidence base.
We turn the economic terms in the pharmaceutical purchasing agreement into rules: rates, thresholds, caps, credits, formulas, and exceptions.
Invoices, statements, usage files, claim data, settlement reports, and performance records run against those rules as they arrive.
Green means in line. Anything else is surfaced with the clause, calculation, period, and counterparty-ready support.
We encode pricing basis, eligibility, chargeback, rebate, and prompt-pay terms, then match them to wholesaler data.